Viatris Inc recalls Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-1817-77) and b) 1000-count bottles…

Recall date

November 18, 2024

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0121-2025

FDA classification

Class II

Brand / firm

Viatris Inc

Sold / distributed

Nationwide within the United States and Puerto Rico

Why it was recalled

Superpotent Drug and Subpotent Drug: potency failures obtained

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-1817-77) and b) 1000-count bottles (NDC 0378-1817-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.